Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis.

Psoriasis (Auckl) · 2017 · PMC5919162 · PMID 29721444

Europe PMC DOI

hedged sentence

0.1730

closest p · 3.5× alpha

0.1730

boldest claim

The sentences

did not reach statistical significancep =0.173not close (p > 0.1)

The reduction in PASI 75 after 4 months was larger in the HLA-Cw6− participants (34.4%) as compared to HLA-Cw6+ patients (25.6%); however, this did not reach statistical significance ( p =0.173).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.